Overcoming Pharmacokinetic and Peripheral Safety Challenges in Psychedelic Therapies: The Promise of Advanced Drug Delivery Systems
ACS Pharmacology & Translational Science · 12.06.2026 · 9 (6) · 1331-1344
DOI: 10.1021/acsptsci.6c00146 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 25.05.2026. Verfasst von Tianshu Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Laboratory for Frontier Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, …. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China, Chinese Academy of Sciences.
Abstract (Originalsprache)
-dimethyltryptamine (DMT)-hold remarkable promise for treating neuropsychiatric disorders, yet their clinical translation is severely constrained by first-pass metabolism, erratic pharmacokinetics, unsuitable action profiles, and off-target peripheral serotonin effects. To overcome these barriers, advanced delivery systemssuch as transdermal and microneedle patches, intranasal sprays, sublingual films, and injectable formulationshave been developed, alongside molecular strategies including prodrugs, "off-switch" 5-HT receptor antagonists for session control, selective receptor bias, and adjunctive pharmacological approaches. These innovations help bypass hepatic metabolism, enable precise control over onset and duration of action, and minimize peripheral receptor activation. Preclinical and early clinical evidence shows gains in bioavailability, half-life extension, and conversion of fleeting psychedelic effects into manageable windows. These platforms offer a path to safer, patient-centered therapies. Despite regulatory and trial-design challenges, delivery innovations provide the essential pharmacokinetic toolkit to advance the field and clinical adoption.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Interdisciplinary Laboratory for Frontier Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, China.
- School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, Anhui 230026, China.
ORCID-Profile: Xiaohui Wang
Förderung
- Ministry of Science and Technology of the People's Republic of China
- National Natural Science Foundation of China
- Chinese Academy of Sciences
- Jilin Province Science and Technology Program
Zitieren
APA
Zhang, T., Lin, C., & Wang, X. (2026). Overcoming Pharmacokinetic and Peripheral Safety Challenges in Psychedelic Therapies: The Promise of Advanced Drug Delivery Systems. ACS Pharmacology & Translational Science, 9(6), 1331-1344. https://doi.org/10.1021/acsptsci.6c00146
Vancouver
Zhang T, Lin C, Wang X. Overcoming Pharmacokinetic and Peripheral Safety Challenges in Psychedelic Therapies: The Promise of Advanced Drug Delivery Systems. ACS Pharmacology & Translational Science. 2026;9(6):1331-1344. doi:10.1021/acsptsci.6c00146
BibTeX
@article{Zhang2026,
author = {Zhang, Tianshu and Lin, Cong and Wang, Xiaohui},
title = {Overcoming Pharmacokinetic and Peripheral Safety Challenges in Psychedelic Therapies: The Promise of Advanced Drug Delivery Systems},
journal = {ACS Pharmacology & Translational Science},
year = {2026},
volume = {9},
number = {6},
pages = {1331--1344},
doi = {10.1021/acsptsci.6c00146}
}
EUVIMED